Breaking News Instant updates and real-time market news.

CIT

CIT Group

$36.40

0.14 (0.39%)

17:12
10/06/16
10/06
17:12
10/06/16
17:12

CIT Group to sell CIT Commercial Air to Avolon Holdings for $10B

CIT Group announced that it has entered into a definitive agreement to sell CIT Commercial Air, its commercial aircraft leasing business, to Avolon Holdings, the international aircraft leasing company and a wholly-owned subsidiary of Bohai Capital Holding Co. The transaction is expected to close by the end of the first quarter of 2017, subject to regulatory approvals and customary closing conditions. CIT has received a "non-objection" from the Federal Reserve Bank of New York for its Amended Capital Plan subject to the closing of the transaction. The Amended Capital Plan authorizes CIT to return $2.975B of common equity to shareholders from the net proceeds of the sale; return up to an additional $0.325B of common equity contingent upon the issuance of a similar amount of Tier 1 qualifying preferred stock; and pay common dividends totaling $64M per year after the transaction is completed, subject to quarterly approval by the CIT Board of Directors. CIT is selling the CIT Commercial Air business to Avolon, including its operations, forward order commitments, and as of June 30, 2016, certain assets of $11.1B and liabilities of $1.7B. The Adjusted Net Assets Amount total $9.4B which Avolon is purchasing for a price of $10B, representing a premium of 6.7%. The transaction is subject to receipt of regulatory approvals in the United States, China and certain other foreign jurisdictions, the approval of Bohai's shareholders and the satisfaction of customary closing conditions. HNA Group, Bohai's majority shareholder, has agreed to vote its shares in Bohai in favor of the transaction. To reflect its commitment to the transaction, Avolon has deposited $500M into an escrow account with a U.S. bank (which will be increased to $600M during the pendency of the transaction), which is payable to CIT at closing as part of the purchase price and in certain circumstances if the transaction is not consummated.

CIT CIT Group
$36.40

0.14 (0.39%)

03/28/16
03/28/16
DOWNGRADE

Neutral
CIT Group downgraded to Neutral from Buy at Sterne Agee CRT
03/28/16
03/28/16
DOWNGRADE

Neutral
CIT Group downgraded at Sterne Agee CRT
As noted earlier, Sterne Agee CRT downgraded CIT Group to Neutral from Buy. As reasons for the downgrade, the firm cited several factors, including the company's admission that it will need more time than expected to achieve its targeted profitability. The firm also cited the higher than expected cost of the spin off of the compsny's air leasing business and its belief that the company's ROE is below that of its peers. Target $37.
04/29/16
BOFA
04/29/16
DOWNGRADE
BOFA
Underperform
CIT Group downgraded to Underperform from Buy at BofA/Merrill
04/29/16
BOFA
04/29/16
DOWNGRADE
BOFA
Follow-up: CIT Group downgraded to Underperform at BofA/Merrill
As previously reported, BofA/Merrill downgraded CIT Group to Underperform from Buy. The firm's analyst said the restructuring to a complex franchise from a simplified bank may be extended until 2018 or longer, due to additional restructuring, a revised strategy, and a management overhaul. BofA/Merrill sees limited earnings visibility and believes sentiment will remain poor until the commercial air exit is complete and execution on the strategic plan shows progress.

TODAY'S FREE FLY STORIES

BOLD

Audentes Therapeutics

$26.57

1.04 (4.07%)

08:02
09/21/17
09/21
08:02
09/21/17
08:02
Hot Stocks
Audentes Therapeutics doses first patient in ASPIRO trial »

Audentes Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELGX

Endologix

$4.29

-0.15 (-3.38%)

08:01
09/21/17
09/21
08:01
09/21/17
08:01
Hot Stocks
Endologix announces CE Mark approval for Nellix system »

Endologix announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$156.07

-2.66 (-1.68%)

08:00
09/21/17
09/21
08:00
09/21/17
08:00
Options
Apple call buyer realizes 32% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

08:00
09/21/17
09/21
08:00
09/21/17
08:00
General news
Treasury Market Outlook: bonds remain mostly weaker »

Treasury Market Outlook:…

NVDA

Nvidia

, TSLA

Tesla

07:58
09/21/17
09/21
07:58
09/21/17
07:58
Technical Analysis
Technical View: AMD trades up on report it is working with Tesla on AI chip »

In the pre-market the AMD…

NVDA

Nvidia

TSLA

Tesla

AMD

AMD

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

JAKK

JAKKS Pacific

$3.15

0.325 (11.50%)

07:56
09/21/17
09/21
07:56
09/21/17
07:56
Downgrade
JAKKS Pacific rating change  »

JAKKS Pacific downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCL

Royal Caribbean

$114.94

-2.98 (-2.53%)

07:56
09/21/17
09/21
07:56
09/21/17
07:56
Conference/Events
Royal Caribbean management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

RMBS

Rambus

$13.35

-0.23 (-1.69%)

07:55
09/21/17
09/21
07:55
09/21/17
07:55
Conference/Events
Rambus to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Oct

MO

Altria Group

$61.22

-1.01 (-1.62%)

07:54
09/21/17
09/21
07:54
09/21/17
07:54
Recommendations
Altria Group analyst commentary  »

Altria cigarette price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCO

Moody's

$136.77

0.03 (0.02%)

07:50
09/21/17
09/21
07:50
09/21/17
07:50
Conference/Events
Moody's management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

LII

Lennox

$170.37

4.54 (2.74%)

07:49
09/21/17
09/21
07:49
09/21/17
07:49
Conference/Events
Lennox management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

  • 26

    Sep

APRN

Blue Apron

$5.22

-0.29 (-5.26%)

07:49
09/21/17
09/21
07:49
09/21/17
07:49
Technical Analysis
Technical View: Blue Apron trades highe as Plated acquired by Albertsons »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IIVI

II-VI

07:48
09/21/17
09/21
07:48
09/21/17
07:48
Conference/Events
II-VI management to meet with B. Riley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

  • 28

    Sep

  • 13

    Nov

HSC

Harsco

$19.70

-0.2 (-1.01%)

07:47
09/21/17
09/21
07:47
09/21/17
07:47
Conference/Events
Harsco management to meet with Lake Street »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

TXN

Texas Instruments

$85.83

-0.98 (-1.13%)

07:44
09/21/17
09/21
07:44
09/21/17
07:44
Recommendations
Texas Instruments analyst commentary  »

Texas Instruments price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$438.17

6.79 (1.57%)

, AMGN

Amgen

$188.17

1.85 (0.99%)

07:44
09/21/17
09/21
07:44
09/21/17
07:44
Recommendations
Regeneron, Amgen, AstraZeneca, AbbVie analyst commentary  »

Regeneron price target…

REGN

Regeneron

$438.17

6.79 (1.57%)

AMGN

Amgen

$188.17

1.85 (0.99%)

AZN

AstraZeneca

$32.93

0.26 (0.80%)

ABBV

AbbVie

$87.41

1.04 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 25

    Sep

  • 27

    Sep

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

ALNY

Alnylam

$113.84

38.8 (51.71%)

07:44
09/21/17
09/21
07:44
09/21/17
07:44
Recommendations
Alnylam analyst commentary  »

Alnylam price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHF

Brighthouse Financial

$57.49

0.56 (0.98%)

07:43
09/21/17
09/21
07:43
09/21/17
07:43
Initiation
Brighthouse Financial initiated  »

Brighthouse Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JKS

JinkoSolar

$26.29

-1.42 (-5.12%)

07:42
09/21/17
09/21
07:42
09/21/17
07:42
Technical Analysis
Technical View: JinkoSolar slips in early trading, analyst action »

Shares were last down 3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GGG

Graco

$122.63

0.77 (0.63%)

07:40
09/21/17
09/21
07:40
09/21/17
07:40
Conference/Events
Graco management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

DATA

Tableau

$75.25

-0.32 (-0.42%)

07:35
09/21/17
09/21
07:35
09/21/17
07:35
Recommendations
Tableau analyst commentary  »

Tableau price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOLD

Amicus

$14.92

0.96 (6.88%)

07:33
09/21/17
09/21
07:33
09/21/17
07:33
Hot Stocks
Amicus ATB200/AT2221 granted Orphan Drug Designation by FDA »

Amicus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAL

Delta Air Lines

$48.04

0.14 (0.29%)

, UAL

United Continental

$58.06

0.52 (0.90%)

07:33
09/21/17
09/21
07:33
09/21/17
07:33
Recommendations
Delta Air Lines, United Continental, American Airlines, Alaska Air, JetBlue, Southwest analyst commentary  »

Recent correction in…

DAL

Delta Air Lines

$48.04

0.14 (0.29%)

UAL

United Continental

$58.06

0.52 (0.90%)

AAL

American Airlines

$45.42

1.04 (2.34%)

ALK

Alaska Air

$73.00

0.76 (1.05%)

JBLU

JetBlue

$19.25

0.21 (1.10%)

LUV

Southwest

$54.25

0.71 (1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

TNTR

Tintri

$3.05

-0.61 (-16.67%)

07:33
09/21/17
09/21
07:33
09/21/17
07:33
Downgrade
Tintri rating change  »

Tintri downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSPR

InspireMD

$0.32

0.0021 (0.65%)

07:32
09/21/17
09/21
07:32
09/21/17
07:32
Hot Stocks
InspireMD announces distribution agreement for CGuard EPS in Portugal »

InspireMD announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.